179 related articles for article (PubMed ID: 37299207)
1. Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope.
Blokhina EA; Mardanova ES; Zykova AA; Stepanova LA; Shuklina MA; Tsybalova LM; Ravin NV
Plants (Basel); 2023 Jun; 12(11):. PubMed ID: 37299207
[TBL] [Abstract][Full Text] [Related]
2. Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin.
Blokhina EA; Mardanova ES; Stepanova LA; Tsybalova LM; Ravin NV
Plants (Basel); 2020 Jan; 9(2):. PubMed ID: 32013187
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection.
Zykova AA; Blokhina EA; Stepanova LA; Shuklina MA; Tsybalova LM; Kuprianov VV; Ravin NV
Nanomedicine; 2022 Jan; 39():102463. PubMed ID: 34583058
[TBL] [Abstract][Full Text] [Related]
4. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.
Mardanova ES; Kotlyarov RY; Kuprianov VV; Stepanova LA; Tsybalova LM; Lomonosoff GP; Ravin NV
BMC Biotechnol; 2015 May; 15():42. PubMed ID: 26022390
[TBL] [Abstract][Full Text] [Related]
5. High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin.
Mardanova ES; Kotlyarov RY; Kuprianov VV; Stepanova LA; Tsybalova LM; Lomonossoff GP; Ravin NV
Bioengineered; 2016; 7(1):28-32. PubMed ID: 26710263
[TBL] [Abstract][Full Text] [Related]
6. Rapid Transient Expression of Receptor-Binding Domain of SARS-CoV-2 and the Conserved M2e Peptide of Influenza A Virus Linked to Flagellin in
Mardanova ES; Kotlyarov RY; Ravin NV
Plants (Basel); 2022 Dec; 11(24):. PubMed ID: 36559537
[TBL] [Abstract][Full Text] [Related]
7. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses.
Wang Q; Zhang Y; Zou P; Wang M; Fu W; She J; Song Z; Xu J; Huang J; Wu F
Front Microbiol; 2020; 11():1961. PubMed ID: 32922379
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection.
Zykova AA; Blokhina EA; Stepanova LA; Shuklina MA; Ozhereleva OO; Tsybalova LM; Kuprianov VV; Ravin NV
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764217
[TBL] [Abstract][Full Text] [Related]
10. High-Yield Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope and Receptor Binding Domain of SARS-CoV-2 in Plants Using Viral Vectors.
Mardanova ES; Kotlyarov RY; Stuchinskaya MD; Nikolaeva LI; Zahmanova G; Ravin NV
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555326
[TBL] [Abstract][Full Text] [Related]
11. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.
Petukhova NV; Gasanova TV; Stepanova LA; Rusova OA; Potapchuk MV; Korotkov AV; Skurat EV; Tsybalova LM; Kiselev OI; Ivanov PA; Atabekov JG
Curr Pharm Des; 2013; 19(31):5587-600. PubMed ID: 23394564
[TBL] [Abstract][Full Text] [Related]
13. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
[TBL] [Abstract][Full Text] [Related]
14. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
Wang W; Huang B; Wang X; Tan W; Ruan L
Virol Sin; 2019 Oct; 34(5):583-591. PubMed ID: 31240620
[TBL] [Abstract][Full Text] [Related]
15. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
[TBL] [Abstract][Full Text] [Related]
16. Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
Hashemi H; Pouyanfard S; Bandehpour M; Noroozbabaei Z; Kazemi B; Saelens X; Mokhtari-Azad T
PLoS One; 2012; 7(9):e45765. PubMed ID: 23029232
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.
Shim BS; Choi YK; Yun CH; Lee EG; Jeon YS; Park SM; Cheon IS; Joo DH; Cho CH; Song MS; Seo SU; Byun YH; Park HJ; Poo H; Seong BL; Kim JO; Nguyen HH; Stadler K; Kim DW; Hong KJ; Czerkinsky C; Song MK
PLoS One; 2011; 6(11):e27953. PubMed ID: 22140491
[TBL] [Abstract][Full Text] [Related]
18. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
Matić S; Rinaldi R; Masenga V; Noris E
BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.
Ni Y; Guo J; Turner D; Tizard I
Vaccine; 2017 Dec; 35(50):7026-7032. PubMed ID: 29102171
[TBL] [Abstract][Full Text] [Related]
20. Production of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine.
Mbewana S; Mortimer E; Pêra FF; Hitzeroth II; Rybicki EP
Front Bioeng Biotechnol; 2015; 3():197. PubMed ID: 26697423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
